ASTRO is pleased to offer the below opportunities for 2022.
Research Grants
ASTRO funds research for junior faculty, residents, fellows, and postdoctoral fellows in support of radiation oncology researchers’ careers. We recommend frequently checking this page for updates on open opportunities.
Career Development Awards
ASTRO-ACS Clinician Scientist Development Grant (NEW)
Application Deadline: April 1, 2022; 11:59 p.m. ET (GMT-5)
This is a joint effort with the American Cancer Society (ACS) to co-fund one Clinician Scientist Development Grant (CSDG). The goal of the ASTRO-ACS CSDG is to foster the research career of a clinician scientist in radiation oncology. At a minimum, to be eligible an applicant must have a clinical doctoral degree with an active license to provide clinical care, or be a medical physicist with a clinical license at the time of the application. The award may be for three to five years with $135,000 a year for direct costs, plus 8% allowable indirect costs. Applications are to be submitted via the ACS portal. To apply and view further eligibility criteria and application instructions, visit the
ACS CSDG website. Questions for this opportunity can be directed to the ASTRO
Department of Scientific Affairs and ACS at
grant.eligibility@cancer.org.
ASTRO-BCRF Career Development Award
Extended Application Deadline: March 4, 2022; 11:59 p.m. ET (GMT-5)
This is a joint effort with the Breast Cancer Research Foundation (BCRF) to support one early career researcher who is either a member of a racial and/or ethnic group traditionally excluded in academic medicine and biomedical research, or studying health disparities to advance breast cancer and radiation oncology research. The award will provide up to $100,000 per year for two years, with the possibility to be extended for up to one more year, if appropriate justification is provided prior to the end of the project period. To apply and view the detailed Program Announcement, visit ProposalCentral.
Residents/Fellows Seed Grants
Application Deadline: February 11, 2022; 11:59 p.m. ET (GMT-5)
The Seed Grants provide up to $25,000 over 1 year. They are designed to foster the research careers of residents and fellows interested in radiation oncology related basic, translational/or clinical research. Applicants must be enrolled in a U.S. residency or fellowship at the time of application. To apply and view the Program Announcement guidelines for each program, visit ProposalCentral.
ASTRO Residents/Fellows in Radiation Oncology Seed Grant
This seed grant will support trainees developing any area of research that has the potential to advance the radiation oncology field.
ASTRO Residents/Fellows in Radiation Oncology Biology Seed Grant
The biology-focused seed grant will support trainees advancing any area of basic biological research related to the radiological or oncology sciences and has the potential to advance the radiation oncology field.
ASTRO-AAPM Physics Residents/Postdoctoral Fellows Seed Grant
This is a joint effort with the American Association of Physicists in Medicine (AAPM) to support the research of medical physics residents and postdoctoral fellows, and advance their careers. The proposed project must be focused on physics-related research in radiation oncology. Applicants (Ph.D. or equivalent) must be a postdoctoral fellow or medical physics resident.
ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant (NEW)
This is a joint effort with the LUNGevity Foundation (LUNGevity) to foster the career advancement of residents or fellows conducting radiation oncology related research for the benefit of patients with lung cancer. Specific areas of interest may include but are not limited to basic, translational, and clinical research, health services research, and population science.
ASTRO-Industry Radiation Oncology Research Training Fellowships
Fellowship Application Deadline: January 7, 2022; 11:59 p.m. ET (GMT-5)
ASTRO is no longer accepting applications for the 2022 Fellowship Program.
These fellowships provide opportunities for early-career physician scientists and scientists to obtain mentored training in an industry setting for up to one year.
ASTRO-AstraZeneca Radiation Oncology Research Training Fellowships
Two fellowships are designed to provide U.S. based residents or other trainees with real-world experience in drug development. The fellows can expect to work on multiple projects with a main focus on late-stage drug development challenges, including novel drug-radiation combinations, either with Immuno-Oncology (“IO”), or anti-epidermal growth factor receptor (“EGFR”) agents.
ASTRO-Nanobiotix Radiation Oncology Research Training Fellowship (NEW)
This fellowship is designed for U.S. based residents or postdoctoral fellows interested in gaining experience across the life cycle of pharmaceutical product development from Phase I through IV. Based on the principles of radiation using nanophysics, the fellow will gain experience in using the principles of radiation to understand combination therapy from translational to clinical research. The fellow will also gain experience in medical affairs and will work with scientific experts globally in radiation, and medical oncology.
ASTRO-Novocure Radiation Oncology Research Training Fellowship (NEW)
Providing an opportunity to spend a year in Israel, this fellowship is designed to provide training and in-depth understanding on Tumor Treating Fields (TTFields) dosimetry and treatment planning through active participation in R&D projects. Targeted candidates are medical physicists or clinicians with backgrounds in engineering or the exact sciences (physics, math, computer sciences).
ASTRO-Varian Radiation Oncology Research Training Fellowship
This fellowship is designed for U.S. based residents and other trainees to receive radiation oncology related training in an industry setting. The fellow can expect to work with Varian in the research and development area(s) of: radiobiology, immunotherapy, applications of artificial intelligence in radiation oncology, information systems, treatment planning, imaging and image-guidance, new hardware for treatment delivery systems, and quality assurance.
For questions please contact the Department of Scientific Affairs.